An indication for a pacemaker or implantable cardioverter-defibrillator (ICD) in a patient with an intracardiac shunt requires a balancing of the risks and benefits associated with a transvenous ...

Please provide your email address to receive an email when new articles are posted on . The world’s first dual-chamber leadless pacing system was named a top invention of 2023. The first implantation ...

ORLANDO, FL — Transvenous pacemaker leads pose a number of potential challenges and risks, including serious infection, so several alternative strategies—such as subcutaneous leads in the case of ...

AKRON, Ohio — How can a novice doctor learn to implant a pacemaker through a vein to save a patient with a deadly slow heart rate? PacerMan to the rescue. Dr. Rami A. Ahmed, an emergency medicine ...

The implantable defibrillator with subcutaneous leads, designed in part to minimize the risk for potentially serious lead-related complications, has reached a milestone by turning in a "noninferior" ...

Please provide your email address to receive an email when new articles are posted on . A dual-chamber leadless pacemaker met 3-month safety and efficacy performance goals. The device avoids ...

A 67-year-old man with acute anterolateral myocardial infarction had recurrent ventricular fibrillation that required insertion of temporary pacemaker. When a permanent pacemaker was inserted stable ...

Patients with intracardiac shunts might at some point require a pacemaker or an implantable cardioverter–defibrillator (ICD). These patients may have numerous thrombotic risk factors, however, and ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- A ...

Pacemaker for heart: A new study suggests heart attack patients should choose leadless pacemakers over the conventional transvenous variants since they have fewer short- and mid-term complications.

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...